BridgeBio Pharma (BBIO) Total Debt Growth (1y) (2019 - 2025)
BridgeBio Pharma (BBIO) Total Debt Growth (1y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BridgeBio Pharma |
12.90 Bn |
11.97 Bn |
184.58 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
3.56% |
| Sep 30, 2025 |
69.73% |
| Dec 31, 2024 |
22.11% |
| Sep 30, 2024 |
-1.25% |
| Jun 30, 2024 |
-1.15% |
| Mar 31, 2024 |
-0.24% |
| Dec 31, 2023 |
3.59% |
| Sep 30, 2023 |
4.43% |
| Jun 30, 2023 |
5.29% |
| Mar 31, 2023 |
0.38% |
| Dec 31, 2022 |
0.06% |
| Sep 30, 2022 |
310.10% |
| Jun 30, 2022 |
307.71% |
| Mar 31, 2022 |
359.83% |
| Dec 31, 2021 |
358.84% |
| Sep 30, 2021 |
10.44% |
| Jun 30, 2021 |
10.44% |
| Mar 31, 2021 |
2.16% |
| Dec 31, 2020 |
2.27% |
| Sep 30, 2020 |
24.49% |
